ASX - By Stock
|
IMU |
Re:
Big buy
|
|
Target2017
|
26 |
17K |
0 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
26
|
17K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Big buy
|
|
Target2017
|
26 |
17K |
2 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
26
|
17K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Target2017
|
16K |
7.7M |
11 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
16K
|
7.7M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Target2017
|
16K |
7.7M |
10 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
16K
|
7.7M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Target2017
|
16K |
7.7M |
2 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
16K
|
7.7M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform'
|
|
Target2017
|
282 |
120K |
0 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
282
|
120K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
Target2017
|
254 |
113K |
41 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
254
|
113K
|
41
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Target2017
|
16K |
7.7M |
6 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
16K
|
7.7M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
Target2017
|
1.8K |
1.0M |
3 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
1.8K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Letter to IMUOA & IMUOB Option Share Holders
|
|
Target2017
|
57 |
26K |
10 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
57
|
26K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr Rita Laeufle as Chief Medical Officer
|
|
Target2017
|
16 |
7.7K |
1 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
16
|
7.7K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr Rita Laeufle as Chief Medical Officer
|
|
Target2017
|
16 |
7.7K |
5 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
16
|
7.7K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr Rita Laeufle as Chief Medical Officer
|
|
Target2017
|
16 |
7.7K |
9 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
16
|
7.7K
|
9
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Gilead Immunomedics takeover
|
|
Target2017
|
7 |
5.7K |
3 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
7
|
5.7K
|
3
|
|
ASX - By Stock
|
IMU |
City of Hope scientists use two powerful immunotherapies to eradicate solid tumors
|
|
Target2017
|
12 |
8.2K |
24 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
12
|
8.2K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Receives PD1-VAXX Ethics Trial Approval in USA
|
|
Target2017
|
197 |
89K |
10 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
197
|
89K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Proposed issue of Securities - IMU
|
|
Target2017
|
64 |
25K |
4 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
64
|
25K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Proposed issue of Securities - IMU
|
|
Target2017
|
64 |
25K |
3 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
64
|
25K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Options and partnership deals
|
|
Target2017
|
5 |
2.2K |
1 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
5
|
2.2K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Options and partnership deals
|
|
Target2017
|
5 |
2.2K |
1 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
5
|
2.2K
|
1
|
|
ASX - By Stock
|
IMU |
Options and partnership deals
|
|
Target2017
|
5 |
2.2K |
2 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
5
|
2.2K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
IMUOC oppies - severly undervalued
|
|
Target2017
|
93 |
53K |
2 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
93
|
53K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
IMUOC oppies - severly undervalued
|
|
Target2017
|
93 |
53K |
2 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
93
|
53K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
IMUOC oppies - severly undervalued
|
|
Target2017
|
93 |
53K |
2 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
93
|
53K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
IMUOC oppies - severly undervalued
|
|
Target2017
|
93 |
53K |
1 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
93
|
53K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
Target2017
|
50 |
25K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
50
|
25K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
Target2017
|
50 |
25K |
5 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
50
|
25K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
Target2017
|
50 |
25K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
50
|
25K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Laurence Fishburne
|
|
Target2017
|
50 |
25K |
5 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
50
|
25K
|
5
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Q&A with CEO
|
|
Target2017
|
26 |
14K |
2 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
26
|
14K
|
2
|
|
ASX - By Stock
|
IMU |
Is Gilead chief Dan O’Day ready for a new biotech deal in the oncology field?
|
|
Target2017
|
9 |
6.9K |
15 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
9
|
6.9K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
KITE PHARMA mimic.
|
|
Target2017
|
15 |
12K |
1 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
15
|
12K
|
1
|
|
ASX - By Stock
|
IMU |
KITE PHARMA mimic.
|
|
Target2017
|
15 |
12K |
7 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
15
|
12K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Latest Facebook Post from Imugene (10/02/20 @1545)
|
|
Target2017
|
26 |
20K |
5 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
26
|
20K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Latest Facebook Post from Imugene (10/02/20 @1545)
|
|
Target2017
|
26 |
20K |
24 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
26
|
20K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Latest Facebook Post from Imugene (10/02/20 @1545)
|
|
Target2017
|
26 |
20K |
11 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
26
|
20K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Valuation - 2020
|
|
Target2017
|
4 |
3.6K |
6 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
4
|
3.6K
|
6
|
|
ASX - By Stock
|
IMU |
Valuation - 2020
|
|
Target2017
|
4 |
3.6K |
21 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
4
|
3.6K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
2020 Vision
|
|
Target2017
|
5 |
4.7K |
5 |
01/01/20 |
01/01/20 |
ASX - By Stock
|
5
|
4.7K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
General Discussion
|
|
Target2017
|
266 |
179K |
3 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
266
|
179K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
General Discussion
|
|
Target2017
|
266 |
179K |
4 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
266
|
179K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
General Discussion
|
|
Target2017
|
266 |
179K |
7 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
266
|
179K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
General Discussion
|
|
Target2017
|
266 |
179K |
2 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
266
|
179K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus
|
|
Target2017
|
86 |
45K |
0 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
86
|
45K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene appoints Dr R Auer to Oncolytic Virotherapy SAB
|
|
Target2017
|
12 |
7.6K |
8 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
12
|
7.6K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Worst of 2019
|
|
Target2017
|
71 |
43K |
1 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
71
|
43K
|
1
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
Target2017
|
2.5K |
1.4M |
3 |
03/12/19 |
03/12/19 |
Charts
|
2.5K
|
1.4M
|
3
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Why have a CR when we have enough cash?
|
|
Target2017
|
89 |
43K |
2 |
30/11/19 |
30/11/19 |
ASX - By Stock
|
89
|
43K
|
2
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
Target2017
|
2.5K |
1.4M |
10 |
21/11/19 |
21/11/19 |
Charts
|
2.5K
|
1.4M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Plebs
|
|
Target2017
|
401 |
301K |
1 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
401
|
301K
|
1
|
|